BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8198091)

  • 1. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
    Schoen RE; Weissfeld JL; Kuller LH
    Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
    Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
    Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population-based case series.
    Re A; Taylor TH; DiSaia PJ; Anton-Culver H
    Gynecol Oncol; 1997 Aug; 66(2):255-7. PubMed ID: 9264572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we colonoscope women with gynecologic cancer?
    Rex D
    Am J Gastroenterol; 2000 Mar; 95(3):812-3. PubMed ID: 10710083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer surveillance during HRT.
    Palacios S
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of breast, endometrial, and ovarian cancers after twin births.
    Ji J; Försti A; Sundquist J; Hemminki K
    Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonbreast second malignancies after treatment of primary breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer.
    Srinivasan R; Yang YX; Rubin SC; Morgan MA; Lewis JD
    Am J Gastroenterol; 2005 Dec; 100(12):2759-64. PubMed ID: 16393232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer.
    Modesitt SC; Gambrell AC; Cottrill HM; Hays LR; Walker R; Shelton BJ; Jordan CE; Ferguson JE
    Obstet Gynecol; 2006 Jun; 107(6):1330-6. PubMed ID: 16738160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
    Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
    Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based screening for hereditary breast cancer in a region of North-Central Italy.
    Casadei S; Falcini F; Naldoni C; Amadori D; Calistri D
    Int J Mol Med; 2002 Sep; 10(3):299-305. PubMed ID: 12165804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for the major malignancies affecting women: current guidelines.
    Paley PJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):1021-30. PubMed ID: 11303215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
    Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
    Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is gynecological cancer a new indication for surveillance colonoscopy in Korea?
    Chang JH; Choi HS; Choi JS; Park DI; Seo HI; Yang MH; Sohn HJ; Lee SY; Jeen YT; Ji JS; Jang BI; Shin JE; Eun CS; Back IH
    Hepatogastroenterology; 2012 May; 59(115):727-30. PubMed ID: 22469715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.